Retinal 0.1 PDRN 5000 Face Cream 20ml
- face cream
Jumiso Retinal 0.1 PDRN 5000 Cream – care focused on firmness and smoothing
Jumiso Retinal 0.1 PDRN 5000 Cream is a face cream created for skin that needs support in improving firmness, smoothness, and overall appearance. The formula is based on a combination of 0.1% retinal, PDRN, and ectoin—ingredients valued in modern skincare for their multi-directional benefits.
It is a great option for those looking for a cream that combines anti-aging care with attention to skin comfort. Thanks to carefully selected active ingredients, the product fits well into a skincare routine focused on improving elasticity and refining the skin’s texture.
Key product benefits
- contains 0.1% retinal—an ingredient known for helping to support smoother-looking skin,
- formula enriched with PDRN, used in skincare cosmetics aimed at promoting a regenerated-looking complexion,
- ectoin helps care for skin comfort and supports protection against dryness,
- the creamy texture makes it easy to incorporate into a daily skincare routine,
- product intended for facial skincare.
Who is this cream suitable for?
This cream will be a good choice for people who want to expand their skincare routine with a retinal product while also looking for a formula focused on firming care. It may be especially appealing to users noticing a loss of elasticity, uneven skin texture, or a need for more intensive smoothing care.
The combination of retinal, PDRN, and ectoin makes this product stand out with a modern approach to skincare—it brings together ingredients associated with renewal, elasticity, and support for the skin barrier. It is a solution for those who value cosmetics with a clearly defined direction of action.
Jumiso Retinal 0.1 PDRN 5000 Cream is a face cream for those who expect skincare focused on smoothing, improving firmness, and achieving a more refined-looking complexion. The well-thought-out combination of active ingredients makes this product a strong fit for a modern, conscious skincare routine.